.3 seem to be the first described monoclonal antibodies to these M. tuberculosis proteins. H105.10 binds to the cross-reactive 65-kDa protein present in mycobact4ria. Epitope mapping of H105.10 was performed by using the M. keprae DNA sublibrary available in bacteriophage Agtll for this antigen and revealed that its epitope resides in the region from amino acids 20 to 54. The 28-, 35-, and 65-kDa antigens isolated by immunoblotting and presented on nitrocellulose to pleural effusion T cells from tuberculosis patients induced a proliferative response, indicating the presence of T-cell epitopes. These observations indicate that two protein antigens should be added to the list of antigens detectable in M. tuberculosis by monoclonal antibodies. The common feature of such proteins, the elicitation of an immune response of limited or broad cross-reactivity for mycobacteria, encourages the search for their role in the pathogenesis of mycobacterioses.
Tuberculosis and leprosy, diseases caused by mycobacteria, represent important subjects of multidisciplinary investigation owing to the urgent need for rapid and reliable diagnostic tests and effective vaccines for disease control, mainly in developing countries.
A large number of monoclonal antibodies (MAbs) have been raised that react with Mycobacterium tuberculosis antigens. Proteins with molecular masses of 71, 65, 38, 23, 19, 14 , and 12 kilodaltons (kDa) have been defined in this way. An international workshop was held to compare and standardize these reagents (H. D. Engers and workshop participants, Letter, Infect. Immun. 51: [718] [719] [720] 1986 ). The more-specific MAb-defined epitopes known to date are present not only in M. tuberculosis preparations but also in preparations of a limited number of closely related species (M. bovis and M. africanum) that constitute the so-called M. tuberculosis complex. Some of these reagents have been used to create new serodiagnostic assays for tuberculosis (12, 14) and to screen genomic DNA libraries of M. tuberculosis in bacteriophage Xgtll (22, 26) . The recombinant antigens isolated by genetic engineering have been used to define the reactivity of specific T-cell clones derived from tuberculosis patients (20) .
It is probable that the immune response to chronic infections due to complex microorganisms such as M. tuberculosis involves more antigenic determinants than those defined by the MAbs reported thus far (19) . Moreover, still-undetected antigens and epitopes could well contain speciesspecific and/or protective M. tuberculosis determinants or could represent molecules which are possible targets for * Corresponding author.
drugs. Strategies to obtain MAbs to such antigens can be devised.
We describe here the specificity of three novel MAbs obtained after a long mouse immunization regimen by using live Mycobacterium bovis bacillus Calmette-Guerin (BCG) and killed M. tuberculosis. Two of the MAbs are of broad cross-reactivity on 12 strains of mycobacteria, whereas the third, H61.3, recognizes only mycobacteria of the M. tuberculosis complex. Direct comparison with well-characterized MAbs indicates that two of the antigens, of 28 (MAb H60. 15) and 35 kDa (MAb H61.3), have not been previously defined by use of the reported anti-M. tuberculosis MAbs, whereas MAb H105.10 recognizes the 65-kDa protein, of which at least 14 different epitopes have already been defined by MAbs (2) .
Since protection from mycobacterial infection is a function of the cell-mediated immune response (3) , it is of interest to determine whether the antigens defined by MAbs contain epitopes recognized by T lymphocytes. The recent development of a proliferative-T-cell assay using nitrocellulose-bound antigens for screening polypeptides with defined molecular weight (25) provides the possibility of direct identification of antigens recognized by human T lymphocytes. We describe here its application to the identification of M. tuberculosis antigens recognized by murine MAbs and involved in the human T-cell response.
MATERIALS AND METHODS
Mycobacterium and antigen preparations. Live lyophilized BCG vaccine was purchased from Istituto Berna, Como, Italy. Lyophilized M. tuberculosis H37Ra and M. butyricum (M. smegmatis) were purchased from Difco (catalog no.
3114-33-8 and 0640-33-7, respectively; DID Italia, Milan, Italy). Escherichia coli Y1090 was grown in LB medium.
To obtain sonically treated material, bacteria were suspended at 10 mg/ml, dialyzed against phosphate-buffered saline (PBS) for 48 h, and sonicated by 15-s pulses at 15-s intervals on ice for a total of 5 min. Less than 5% of the bacilli were found to be intact by microscopy after such treatment. The sonically treated material was then centrifuged at 600 x g for 10 min, and the supernatant was designated sonic extract and used as indicated. In some experiments, a fraction designated cytoplasm preparation was prepared by centrifugation of sonic extracts at 16,000 x g for 20 min followed by filtration of the supernatant through 0.2-p.m-pore-size membrane filters (Millipore Corp.). The pellet was resuspended in PBS and designated the cell wall preparation.
Cell suspensions of a panel of 11 strains and species of mycobacteria, cultured as described previously (26) , were kindly made available by C. Grossinsky (Albert Einstein College of Medicine, Bronx, N.Y.). To test differential binding of MAbs to these strains and to strain H37Ra (Difco), bacteria were homogenized as described previously (26) . Briefly, 1 ml of acid-washed glass beads was added to 0.2 ml of pelleted bacteria (which had been heated previously for 20 min at 70°C), and the mixture was homogenized for 2 min in a Braun rotary homogenizer. Preparations of disrupted mycobacteria were then centrifuged at 600 x g for 10 min, and the supernatant was used to coat polyvinyl chloride (PVC) microtiter plates.
Mice, immunizations, and hybridomas. BALB/c mice were injected subcutaneously five times at 20-day intervals with approximately 25 pul of an emulsion containing 0.5 mg of lyophilized live BCG vaccine per ml and 2.5 mg of M. tuberculosis per ml of incomplete Freund adjuvant (Behring, Scoppito, Italy). Four days after the sixth injection of emulsion (intraperitoneal), one of the mice was sacrificed and 17.5 x 107 spleen cells were fused with 3.5 x 107
P3X63Ag8U.1 myeloma cells as previously described (5) . After fusion, cells were suspended in selective HAT (hypoxanthine-aminopterin-thymidine)-containing medium and seeded in 144 wells (six 24-well trays) at 0.25 x 106 myeloma cells per well.
Screening of hybridoma supernatants was performed by indirect radioimmunobinding (RIA) on M. tuberculosis H37Ra sonic extract in multiwell plastic plates as described below. Cloning of positive hybridomas in soft agar, production of ascitic fluid, purification of antibodies from ascites, and radioiodination by the chloramine T method of Greenwood et al. (11) were performed as previously reported (5 (17) . Sonic extracts of mycobacteria at a protein concentration of 1 mg/ml were added with sample buffer and loaded onto the gels.
In some experiments, before gel electrophoresis, mycobacterial sonic extracts ( Blotting was performed for 2 h at 4°C at 400 mA in Trisglycine-methanol buffer, pH 8.5. After reactive sites were blocked with 30% fetal calf serum in PBS for 30 min, 5-mm-wide strips were cut out of the nitrocellulose paper and each strip was reacted with MAb culture supernatant in a separate tube for 18 h at 4°C. Bands formed by immunocomplexes were evidenced by adding goat anti-mouse IgG affinity-purified antibodies coupled to horseradish peroxidase (catalog no. P-8375; Sigma Chemical Co., St. Louis, Mo.) by the method of Farr and Nakane (10) . O-Dianisidine (Sigma; catalog no. D-9143) dissolved in methanol was used as the chromogenic substrate. In some experiments, a biotinavidin-based ABC kit (PK 4002; Vector Laboratories, Burlingame, Calif.) was used as the developing system. In each experiment, molecular weight standards (molecular weight markers kit, catalog no. MW-SDS-70L; Sigma) were also subjected to blotting after SDS-PAGE and were stained with amido black. In the experiments involving T-cell cultures, the blotted nitrocellulose strips were saturated and cut at the level of proteins recognized by the three MAbs. Several small disks with a diameter corresponding to that of the culture microtiter well were prepared and inserted on the bottom of each well of the plate.
Determination of the epitope of MAb H105.10. The epitope of MAb H105.10 was determined by the use of Agtll lysogenic E. coli clones as previously described (16) . Briefly, cell lysates of selected lysogenic clones from the sublibrary of the 65,000-molecular-weight-M. leprae-protein gene obtained by Mehra et al. (18) were subjected to SDS-PAGE and blotting. The blots were reacted with H105.10 ascites at a 1:1,000 dilution, and immunocomplex formation was evi-denced by immunoperoxidase-coupled second antibody. Two of the recombinant clones used (Y3143 and Y3150) were from an M. tuberculosis DNA library (13) .
Preparation of lymphocytes and proliferation assay. Fresh and cryopreserved cells from the ascitic pleural effusions of two patients, an 18-year-old male and a 21-year-old female, with primary tuberculous infections (with pleurisy) and with positive skin tests to purified protein derivative (PPD) were used. After centrifugation on a discontinuous density gradient on Ficoll-Hypaque, the cells were suspended in RPMI 1640 medium supplemented with 10% heat-inactivated pooled human serum, 2 mM glutamine, and 100 U of penicillin and 100 ,ug of streptomycin per ml. More than 80% of the cells were T lymphocytes, as determined by immunofluorescence using anti-CD3 antibodies. These cell populations contained a high precursor frequency of mycobacterium-specific T cells, as determined by limiting-dilution analysis (1/1,000 and 1/2,000).
Cells (106/ml) were cultured in 96-well flat-bottom microtiter plates for 6 days with different concentrations of PPD (Serum Institute, Copenhagen, Denmark) and H37Ra (Difco). Solid-phase antigen was prepared in two ways: by dotting different concentrations of PPD or H37Ra on small nitrocellulose disks and by blotting H37Ra extracts on nitrocellulose strips as described above. After 5 days of incubation, the cultures were resuspended and the nitrocellulose disks were discarded prior to the addition of radioac- proteinase K, caused the disappearance of the bands after immunoblotting for all three MAbs. Diminished binding, from 12 to 35% that of the untreated control, was also observed in RIA after treatment of the sonic extract with proteinase K before coating of microtiter plates (data not shown). This indicates the proteinaceous nature of at least part of the three recognized epitopes.
Experiments involving binding of MAbs to the cytoplasmic preparation and to the cell wall preparation of sonic extracts of strain H37Ra indicated that H60.15 was present in both the cytoplasmic and cell wall preparations, whereas H61.3 and H105.10 recognized antigens associated mostly with the cell wall ( (18) . This has been shown to be the N-terminal residue in the naturally occurring 65-kDa protein (9) .
b Recombinant clone from the M. tuberculosis DNA library in Xgtll. MAbs. MAbs WTB-71 and WTB-72 recognize a protein of 38 kDa, quite different in molecular mass from that recognized by MAb H61.3. Moreover, the 38-kDa protein has been purified from the soluble fraction of M. tuberculosis H37Rv after ultracentrifugation and filtration through a 0.45-,umpore-size filter (24) , whereas the antigen recognized by MAb H61.3 is associated mostly with the cell wall of M. tuberculosis H37Ra. A protein of 35 kDa recognized in sonic extracts of M. tuberculosis by antibodies present in the sera of tuberculosis patients has been studied recently (21) . M. tuberculosis antigen 5, purified on conventional immunoadsorbents, presents with a molecular mass of 28,500 to 35,000 Da and a limited cross-reactivity in skin tests (7, 8) . The possibility that these antigens could be related to the H61.3 antigen merits further investigation.
Minor bands of lower molecular mass were stained by both H60.15 and H61.3 in immunoblotting. The multiband appearance of MAb-defined mycobacterial antigens is a recurrent feature and has been explained in several ways (15 Therefore, H105.10 seems to recognize an epitope in the same region as that recognized by MAbs Y1.2 and C1.1 (18) . In fact, Y1.2 and C1.1 also recognize predominantly a 65-kDa band on blots of mycobacterial lysates, whereas most of the other described anti-65-kDa MAbs stain several bands, mainly of 55 and 65 kDa. The finding that the epitope in the region of amino acids 20 to 54 is detectable only on the 65-kDa molecular species of the antigen suggests the presence of a preferential proteolytic target site near the NH2 terminus of the protein.
The antigens of H60.15, H61.3, and H105.10 have been found to be associated mostly with crude cell wall fractions of M. tuberculosis. The H60.15 antigen seems to be present also in the soluble fraction, and an alternative explanation for this phenomenon could be the reported release of molecules from mycobacterial membranes by sonication (1) .
The observed greater extent of binding of the supernatants of the three MAbs to the strain H37Ra preparation (Table 2) seems to be the result of the sonication of strain H37Ra and the disruption of the other strains, since such a difference was not observed when ascites and sonicated mycobacteria were used. This suggests a differential release of antigens by the two methods.
Screening of antibodies in patient sera for the same epitopes recognized by mouse MAb indicates that some of the known MAb-defined epitopes elicit a significant humoral immune response also in humans (12, 14) . Moreover, epitopes on the same antigens of M. tuberculosis present in recombinant DNA libraries have been demonstrated to elicit T-cell clone responses of restricted specificity (20) .
T-and B-cell epitopes need not be identical, as was found for other antigens. The development and application of SDS-PAGE and immunoblotting for screening of antigens recognized by T lymphocytes allows the identification and comparison of T-and B-cell mycobacterial epitopes. By using three MAbs, we have identified three different proteins containing T-cell epitopes, as they induce T-cell proliferation when added to ascitic cell cultures. The T-cell epitopes present in the 65-kDa antigen have been mapped previously by using recombinant antigens and synthetic peptides (16) . In such a study, two regions mapping between residues 66 and 86 and between residues 391 and 413 have been shown to contain human T-cell epitopes which are distinct from the known B-cell epitopes of the 65-kDa protein. However, the selection of T-cell epitopes is a function of the major histocompatibility class II molecules present.
No information is available at present on the T-cell epitopes present in the 28-and 35-kDa M. tuberculosis proteins. The recent finding that recombinant proteins recognized by MAbs H60.15 and H61.3 are able to induce T-cell proliferation (D. Vismara et al., submitted for publication) indicates the possibility of defining both the T-and B-cell epitopes by DNA technology and peptide synthesis. These aspects of the reactivity of the new MAbs described here are under investigation. In any case, a better knowledge of the enzymes or proteins associated with the cell wall would be useful in understanding peculiar aspects of the biochemistry of mycobacteria. However, immunocytochemistry of cells obtained from the bronchoalveolar lavage of three tuberculous patients with H61.3 antibodies has shown that the 35-kDa protein is present inside macrophages, suggesting the relevance of this protein during M. tuberculosis infection (G. Barbolini et al., manuscript in preparation).
The detection by MAb of the two new epitopes of 28-and 35-kDa proteins described in this paper may be due to the immunization schedule, since in the same fusion experiment several MAbs were directed to proteins of 28 and 35 kDa. The presence of the epitopes on the protein molecules of 28 and 35 kDa with broad and limited cross-reactivity, respectively, confirms the predominance of abundant cross-reactive antigens in the humoral immune response to mycobacteria.
It has been found recently that several of the antigens recognized by an antibody in M. leprae and M. tuberculosis, including 65-kDa antigens, are highly conserved proteins with DNA and antigen homologies to heat shock or stress proteins (D. B. Young et al., Proc. Natl. Acad. Sci., in press). It will be of interest to ascertain whether the new antigens recognized here are also stress proteins and to learn whether such proteins are effective or poor immunogens for cell-mediated immunity.
